Pharma Expert Series: GlaxoSmithKline PLC

Confinement, social distancing, lockdown... the world is trying every measure to slow down the pandemic which caused with more than 2,00,000 deaths and over 3 million cases globally. However eventually the only way to actually prevent people from catching Covid-19 is with a vaccine. Nearly 80 companies and academic institutions are racing to produce one. GlaxoSmithKline a leading vaccine manufacturer recently collaborated with Sanofi to develop a COVID Vaccine.
Anshuman Gupta, Pharma Analyst, Investec India spoke with James Dodwell, Director, Investor Relations & Danielle Smith, Director, Investor Relations to get insights into the Vaccine development and potential, new businesses and market opportunities.